Lumos has specific expertise in developing assays across a range of POC, chemistry and technology platforms. These can be configured as stand alone, manual read products or interfaced with Lumos and/or third party hardware for fully automated solutions.
We use our well tested, internally established assay development methods to reduce risk and deliver stable high performance products. Our expertise includes biomarker discovery, reagent development and selection, and assay optimization.
Our assay platforms cover a range of POC method types, from lateral flow and microfluidics to immunoassay and molecular methodologies. Each platform contains well tested, internally established assay methods to reduce risk and deliver stable, high performance products. We strive to continually improve upon the performance of our assay platforms, including the evaluation of novel chemistries and detection technologies.